N-acetylcysteine (NAC) ameliorates Epstein-Barr virus latent membrane protein 1 induced chronic inflammation
Fig 6
NAC treatment does not impact a set of proteins deregulated by LMP1.
Ear tissue protein samples, taken from different mice were analysed by western blotting for expression of the indicated proteins. (A) Samples from L2LMP1 transgene positive mice of increasing age and stage are shown. (B) Samples were taken from NAC treated and control mice at 100 days old. LMP1 transgenic status (+ or -) and NAC treatment (+ or -) are indicated above. Actin or GAPDH was used as a loading control. Protein size markers in kD are indicated to the left of each panel.